Tag: diabetes

Merck and Utah University Found Potential Drug Target for Diabetes

Merck Research Laboratories and the University of Utah Health have shown that deactivation of the dihydroceramide desaturase 1 (DES1) enzyme could offer a potential drug target for metabolic diabetes....

Apexan Pharmaceuticals Got $2.3 mln from NHLBI for Study

Apexan Pharmaceuticals has announced that The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a $2.3 million grant to Dr. Reuben Kapur and Dr. M...

EU CHMP Gives AstraZeneca Positive Opinion for DECLARE-TIMI 58 Cardiovascular Outcomes Data

AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change to the European marketing authorisation for Forxiga (dapaglifl...

CHMP Recommends Treatment for Paediatric Type 2 Diabetes

EMA’s human medicines committee (CHMP) has recommended granting an extension of indication to Victoza (liraglutide) to include the treatment of children and adolescents aged 10 years or older with typ...

FDA Warns Patients over Certain Medtronic Insulin Pumps

The U.S. Food and Drug Administration is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks and recommends ...

FDA Approved Novo Nordisk’s Victoza

The U.S. Food and Drug Administration approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approve...

Abbott Launched Test To Detect Diabetes

blood-sugar
Abbott announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the first and only rapid poin...

Abbott Announced New Data on Continuous Glucose Monitoring Technology

Abbott announced new data showing use of its FreeStyle Libre system, the company's revolutionary continuous glucose monitoring (CGM) technology, significantly reduced hemoglobin A1c (HbA1c) levels for...

Sanofi Diabetes Treatment Phase 3 Results Showed Significant Reduction in Blood Sugar Levels

In a Phase 3 study1 evaluating adults with type 2 diabetes inadequately controlled by GLP-1 receptor agonist (GLP-1 RA) treatments, Soliqua® /Suliqua®2 (insulin glargine 100 Units/mL and lixisenatide)...

Novartis and Sumitomo Signed Collaboration Agreement for Diabetes Treatments in Japan

Sumitomo Dainippon Pharma Co., Ltd. signed a co-promotion and sales collaboration agreement with Novartis Pharma K.K. for Equa® 50mg tablets (generic name: vildagliptin; hereinafter “Equa”), a selecti...

FDA Warns over Risks Using Unapproved Devices for Diabetes Management

fda
The U.S. Food and Drug Administration is warning patients and health care professionals of risks associated with the use of unapproved or unauthorized devices for diabetes management, including contin...

Allergan Announced the Expansion of the PLEDGE Program in Diabetic Gastroparesis

allergan
Allergan plc announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational, ghrelin agonist being studied for the treatment of diabetic gastroparesis ...

Harvard-led Research Boosts Cell Therapy for Diabetes

diabetes drugs
A team of researchers led by Harvard University scientists has improved the laboratory process of converting stem cells into insulin-producing beta cells, using biological and physical separation meth...

AstraZeneca Qternmet XR Approved in the USA

The US Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to diet and exercise t...

Forxiga Got Another Approval

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Forxiga (dapagliflozin) as an oral adjunct treatment to insulin for adults with type-1 diabetes (T1D). Elisabeth Björk, Senio...

First Approved AZ’s Med for Type-1 Diabetes

Forxiga is the first oral medicine approved in Europe as an adjunct to insulin for adults with type-1 diabetes and the first AstraZeneca medicine ever approved for type-1 diabetes. The European Com...